OR WAIT null SECS
May 03, 2023
mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
May 02, 2023
This specific guidance refers to a DCT as a clinical trial where some or all the trial-related activities occur at locations other than traditional clinical trial sites.
The new research and development capacities set the stage for completion of product development for LEON’s manufacturing devices and will be used to showcase the devices and provide process development services to clients using LEON’s equipment.
The acquisition was completed through the merger of a wholly owned subsidiary of Sanofi with and into Provention Bio.
Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.
April 28, 2023
The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.
clonoSEQ Assay is authorized by FDA for MRD assessment in lymphoid malignancies and is highly accurate, sensitive, and standardized compared to other technologies used for disease burden assessment.
April 26, 2023
The results found that repeatability testing found all 15 processes to be with in specification for target final concentration.
April 25, 2023
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.